Literature DB >> 1955162

Circadian pattern of intragastric acidity in duodenal ulcer patients: a study of variations in relation to ulcer activity.

S Wagner1, U Gladziwa, M Gebel, A Schüler, J Freise, F W Schmidt.   

Abstract

The relation between intragastric acidity and duodenal ulcer activity was studied prospectively in 21 patients with endoscopically proved duodenal ulcers. The 24 hour intragastric acidity was measured on four separate occasions by continuous recording using combined glass electrodes: (a) in the presence of an ulcer crater without treatment; (b) during active ulceration being treated with ranitidine; (c) during early healing after a six week course of ranitidine; (d) during late healing six months after acute ulceration. Intragastric acidity was also monitored in 20 healthy subjects. At all stages of ulcer activity and during all predefined time periods, duodenal ulcer patients had significantly higher gastric acidity than healthy control subjects. Duodenal ulcer patients showed a similar circadian pattern of intragastric acidity during exacerbation of ulcer disease and in remission during the early and late ulcer healing periods. These results argue against a direct relation between the activity of duodenal ulcer disease and gastric acidity. It is concluded that the chronic recurrent course of duodenal ulcer disease does not result from a fluctuation in intragastric acidity.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1955162      PMCID: PMC1379367          DOI: 10.1136/gut.32.10.1104

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  31 in total

1.  Basal gastric secretion in patients with duodenal ulcer: a long term study of variations in relation to ulcer activity.

Authors:  A LITMAN
Journal:  Gastroenterology       Date:  1962-08       Impact factor: 22.682

2.  Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori.

Authors:  B J Marshall; C S Goodwin; J R Warren; R Murray; E D Blincow; S J Blackbourn; M Phillips; T E Waters; C R Sanderson
Journal:  Lancet       Date:  1988 Dec 24-31       Impact factor: 79.321

3.  Pepsins of patients with peptic ulcer.

Authors:  W H Taylor
Journal:  Nature       Date:  1970-07-04       Impact factor: 49.962

4.  Duodenal and antral mucosal prostaglandin E2 synthesis in a study of normal subjects and all stages of duodenal ulcer disease treated by H2 receptor antagonists.

Authors:  S Pugh; S E Williams; M R Lewin; M Ishaque; T P Barton; K Bose; K D Bardhan; C G Clark
Journal:  Gut       Date:  1989-02       Impact factor: 23.059

5.  [Epidemiology and therapy of Campylobacter pylori infection].

Authors:  S Wagner; J Freise; W Bär; S Fritsch; F W Schmidt
Journal:  Dtsch Med Wochenschr       Date:  1989-03-17       Impact factor: 0.628

6.  Gastric acid secretion rate and buffer content of the stomach after eating. Results in normal subjects and in patients with duodenal ulcer.

Authors:  J S Fordtran; J H Walsh
Journal:  J Clin Invest       Date:  1973-03       Impact factor: 14.808

7.  Continuous 24-hour intragastric pH monitoring in the evaluation of the effect of a nightly dose of famotidine, ranitidine and placebo on gastric acidity of patients with duodenal ulcer.

Authors:  V Savarino; G S Mela; P Scalabrini; E Di Timoteo; M R Magnolia; G Celle
Journal:  Digestion       Date:  1987       Impact factor: 3.216

8.  Impaired proximal duodenal mucosal bicarbonate secretion in patients with duodenal ulcer.

Authors:  J I Isenberg; J A Selling; D L Hogan; M A Koss
Journal:  N Engl J Med       Date:  1987-02-12       Impact factor: 91.245

9.  Gastric pepsin and acid secretion in patients with acute and healed duodenal ulcer.

Authors:  J L Achord
Journal:  Gastroenterology       Date:  1981-07       Impact factor: 22.682

10.  Comparison of gastric acid secretion rates and serum pepsinogen I and II concentrations in Occidental and Oriental duodenal ulcer patients.

Authors:  M Feldman; C T Richardson; S K Lam; I M Samloff
Journal:  Gastroenterology       Date:  1988-09       Impact factor: 22.682

View more
  9 in total

1.  Problems with the interpretation of gastric pH measurement.

Authors:  D A Johnston; K G Wormsley
Journal:  Clin Investig       Date:  1993-12

2.  Maintenance of intragastric pH > 4 with famotidine in duodenal ulcer patients: factors influencing drug requirements.

Authors:  J C Delchier; F Roudot-Thoraval; L Stanescu; M C Deharvengt; L Elouaer Blanc
Journal:  Gut       Date:  1994-06       Impact factor: 23.059

3.  Effect of Helicobacter pylori infection on 24 hour intragastric acidity in patients with gastritis and duodenal ulcer.

Authors:  S Wagner; U Gladziwa; K Haruma; M Varrentrapp; M Gebel
Journal:  Gut       Date:  1992-08       Impact factor: 23.059

Review 4.  Pharmacokinetic optimisation of the treatment of peptic ulcer in patients with renal failure.

Authors:  U Gladziwa; U Koltz
Journal:  Clin Pharmacokinet       Date:  1994-11       Impact factor: 6.447

5.  Role of meteorological factors in duodenal ulcer seasonality: a nation-wide, population-based study.

Authors:  Sudha Xirasagar; Herng-Ching Lin; Chin-Shyan Chen
Journal:  J Gen Intern Med       Date:  2007-08-01       Impact factor: 5.128

6.  Muscarinic receptors in gastric mucosa are increased in peptic ulcer disease.

Authors:  A Pfeiffer; W Krömer; J Friemann; M Ruge; M Herawi; M Schätzl; U Schwegler; B May; H Schatz
Journal:  Gut       Date:  1995-06       Impact factor: 23.059

7.  Variability in individual response to various doses of omeprazole. Implications for antiulcer therapy.

Authors:  V Savarino; G S Mela; P Zentilin; P Cutela; M R Mele; S Vigneri; G Celle
Journal:  Dig Dis Sci       Date:  1994-01       Impact factor: 3.199

8.  Pharmacokinetics and pharmacodynamics of roxatidine in patients with renal insufficiency.

Authors:  U Gladziwa; S Wagner; H G Sieberth; U Klotz
Journal:  Br J Clin Pharmacol       Date:  1995-02       Impact factor: 4.335

9.  Genetic ablation of carbonic anhydrase IX disrupts gastric barrier function via claudin-18 downregulation and acid backflux.

Authors:  T Li; X Liu; B Riederer; K Nikolovska; A K Singh; K A Mäkelä; A Seidler; Y Liu; G Gros; H Bartels; K H Herzig; U Seidler
Journal:  Acta Physiol (Oxf)       Date:  2017-10-19       Impact factor: 6.311

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.